Based on SEC filing data. A corporation founded in 2020 and based in South San Francisco, CA raised $23.3M in Series B equity funding. The company is in an early growth stage of development.
Get notified the moment Switch Therapeutics Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.